Jefferies has upgraded Kodiak Sciences Inc. (NASDAQ:KOD), a biopharmaceutical company focused on retinal (eye) diseases.

The 2009 Yamaha Kodiak 450 comes with a lot of nice features so many have grown to love: the Ultramatic transmission making operation easy and simple, the on-command 4WD with front differential ...

Neal Dingmann, an analyst from Truist Financial, maintained the Buy rating on Kodiak Gas Services, Inc. (KGS – Research Report). The associated ...

TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timing their transactions. By upgrading to TipRanks Premium, you will gain access to this exclusive data and ...

Debt Management: Kodiak Gas Services's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 2.13. The Basics of Analyst Ratings Benzinga tracks 150 ...

Tarcocimab Phase 3 trials, GLOW2 and DAYBREAK, actively enrolling for retinal diseases. Kodiak stock could reach $20 or a $1 billion+ market cap, Jefferies notes. Jefferies has upgraded Kodiak ...